• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.

作者信息

Di Filippo Massimiliano, Cordioli Cinzia, Malucchi Simona, Annovazzi Pietro, Cavalla Paola, Torri Clerici Valentina, Ragonese Paolo, Nociti Viviana, Radaelli Marta, Laroni Alice, Buttari Fabio, Lorefice Lorena, Ferraro Diana, Gajofatto Alberto, Prosperini Luca, Fantozzi Roberta, Boffa Laura, Lanzillo Roberta, Moccia Marcello, Clerico Marinella, De Luca Giovanna, Tomassini Valentina, Calabrese Massimiliano, Borrelli Angela, Paolicelli Damiano, Maniscalco Giorgia Teresa, Gazzola Paola, Gallo Antonio, Solaro Claudio, Cocco Eleonora, Gasperini Claudio, Tortorella Carla

机构信息

Clinica Neurologica, Dipartimento di Medicina e Chirurgia, University of Perugia, Perugia, Umbria, Italy

Centro Sclerosi Multipla, ASST Spedali Civili di Brescia, Ospedale di Montichiari, Brescia, Italy.

出版信息

J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug 18.

DOI:10.1136/jnnp-2021-327200
PMID:34408003
Abstract
摘要

相似文献

1
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.信使核糖核酸新冠疫苗不会增加多发性硬化症临床复发的短期风险。
J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug 18.
2
COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.新型冠状病毒肺炎（COVID-19）mRNA 疫苗（辉瑞-生物科技和 Moderna）在多发性硬化症患者中的应用：波兰神经病学会多发性硬化症和神经免疫学分会召集的工作组的一份声明。
Neurol Neurochir Pol. 2021;55(1):8-11. doi: 10.5603/PJNNS.a2021.0016. Epub 2021 Feb 8.
3
[Vaccination against SARS-CoV-2 in patients with multiple sclerosis].[多发性硬化症患者的新型冠状病毒2型疫苗接种]
Rev Neurol. 2021 Apr 1;72(7):250-260. doi: 10.33588/rn.7207.2021097.
4
'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.接种 BNT162b2 mRNA COVID-19 疫苗后出现“蓝色脚趾”。
J Travel Med. 2021 Jun 1;28(4). doi: 10.1093/jtm/taab024.
5
In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.简而言之：为免疫功能低下者接种第三剂基于mRNA的新冠疫苗。
Med Lett Drugs Ther. 2021 Sep 20;63(1633):145-146.
6
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.COVID-19 疫苗接种后多发性硬化症患者对第三剂 SARS-CoV-2 疫苗的免疫原性和安全性：免疫应答较弱。
JAMA Neurol. 2022 Mar 1;79(3):307-309. doi: 10.1001/jamaneurol.2021.5109.
7
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
8
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic.新冠疫情时代的疫苗接种与多发性硬化症
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1033-1043. doi: 10.1136/jnnp-2021-326839. Epub 2021 Aug 5.
9
Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine.在紧邻接种SARS-CoV-2 mRNA疫苗处注射醋酸格拉替雷后出现尼科劳综合征。
Neurol Neuroimmunol Neuroinflamm. 2021 Nov 10;9(1). doi: 10.1212/NXI.0000000000001112. Print 2022 Jan.
10
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.COVID-19 疫苗接种在多发性硬化症患者中的应用：截至 2021 年 2 月的研究进展。
Mult Scler. 2021 May;27(6):864-870. doi: 10.1177/13524585211003476. Epub 2021 Apr 15.

引用本文的文献

1
COVID-19 and multiple sclerosis: challenges and lessons for patient care.2019冠状病毒病与多发性硬化症：患者护理面临的挑战与经验教训
Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep.
2
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines.接受新冠病毒疫苗的自身免疫性风湿病患者的临床疾病活动情况。
BMC Rheumatol. 2024 Jun 17;8(1):25. doi: 10.1186/s41927-024-00396-5.
3
Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis.
严重急性呼吸综合征冠状病毒2型疫苗在自身免疫性神经系统疾病患者中的安全性：一项系统评价和荟萃分析。
Heliyon. 2023 Dec 23;10(1):e23944. doi: 10.1016/j.heliyon.2023.e23944. eCollection 2024 Jan 15.
4
COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark.COVID-19 疫苗接种与复发活动：丹麦一项全国性多发性硬化症患者队列研究。
Eur J Neurol. 2024 Mar;31(3):e16163. doi: 10.1111/ene.16163. Epub 2023 Nov 28.
5
Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021).伊朗克尔曼沙阿地区多发性硬化症患者中阿斯利康疫苗和国药疫苗1剂次副作用的比较（2021年）
Curr J Neurol. 2023 Jan 5;22(1):8-15. doi: 10.18502/cjn.v22i1.12611.
6
Vaccination frequency in people newly diagnosed with multiple sclerosis.新发多发性硬化症患者的疫苗接种频率。
Mult Scler. 2023 Dec;29(14):1831-1840. doi: 10.1177/13524585231199084. Epub 2023 Oct 13.
7
The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review.严重急性呼吸综合征冠状病毒 2 感染和疫苗在多发性硬化症发病和再激活中的潜在作用：病例系列和文献复习。
Viruses. 2023 Jul 18;15(7):1569. doi: 10.3390/v15071569.
8
Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review.克拉屈滨片的作用机制：从大流行中汲取经验的叙述性综述
Neurol Ther. 2023 Oct;12(5):1477-1490. doi: 10.1007/s40120-023-00520-6. Epub 2023 Jul 8.
9
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.ECTRIMS/EAN 关于多发性硬化症患者接种疫苗的共识：在高度活跃的免疫治疗药物时代改进免疫策略。
Mult Scler. 2023 Jul;29(8):904-925. doi: 10.1177/13524585231168043. Epub 2023 Jun 9.
10
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience.mRNA COVID-19 疫苗加强针在多发性硬化症患者中的安全性和有效性：一项单中心经验。
Mult Scler Relat Disord. 2023 Apr;72:104582. doi: 10.1016/j.msard.2023.104582. Epub 2023 Feb 24.